Answers are grounded in this paper and cite their sources.
Experimental molecular study reveals that c-Cbl acts as a RING-type ubiquitin ligase targeting activated receptor tyrosine kinases, uncovering a distinct mechanism for substrate degradation.
Ubiquitination of receptor protein-tyrosine kinases (RPTKs) terminates signaling by marking active receptors for degradation. c-Cbl, an adapter protein for RPTKs, positively regulates RPTK ubiquitination in a manner dependent on its variant SRC homology 2 (SH2) and RING finger domains. Ubiquitin-protein ligases (or E3s) are the components of ubiquitination pathways that recognize target substrates and promote their ligation to ubiquitin. The c-Cbl protein acted as an E3 that can recognize tyrosine-phosphorylated substrates, such as the activated platelet-derived growth factor receptor, through its SH2 domain and that recruits and allosterically activates an E2 ubiquitin-conjugating enzyme through its RING domain. These results reveal an SH2-containing protein that functions as a ubiquitin-protein ligase and thus provide a distinct mechanism for substrate targeting in the ubiquitin system.
No takes yet. Share an insight, caveat, or question.
Joazeiro et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: